131 related articles for article (PubMed ID: 37822261)
1. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study.
Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
BJOG; 2024 May; 131(6):823-831. PubMed ID: 37822261
[TBL] [Abstract][Full Text] [Related]
2. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
3. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth.
Celik E; Melekoğlu R; Baygül A; Kalkan U; Şimşek Y
J Obstet Gynaecol; 2022 Aug; 42(6):1956-1961. PubMed ID: 35620869
[TBL] [Abstract][Full Text] [Related]
5. Prediction of spontaneous preterm birth and preterm prelabor rupture of membranes using maternal factors, obstetric history and biomarkers of placental function at 11-13 weeks.
Chiu CPH; Feng Q; Chaemsaithong P; Sahota DS; Lau YY; Yeung YK; Yim LW; Chung JPW; Poon LC
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):192-199. PubMed ID: 35445767
[TBL] [Abstract][Full Text] [Related]
6. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
[TBL] [Abstract][Full Text] [Related]
7. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
[TBL] [Abstract][Full Text] [Related]
8. Routine first-trimester pre-eclampsia screening and risk of preterm birth.
Giorgione V; Quintero Mendez O; Pinas A; Ansley W; Thilaganathan B
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):185-191. PubMed ID: 35441764
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum biomarkers of placental insufficiency at 24-28 weeks of pregnancy in relation to the risk of delivering small-for-gestational-age infant in Sylhet, Bangladesh: a prospective cohort study.
Rahman S; Islam MS; Roy AK; Hasan T; Chowdhury NH; Ahmed S; Raqib R; Baqui AH; Khanam R
BMC Pregnancy Childbirth; 2024 Jun; 24(1):418. PubMed ID: 38858611
[TBL] [Abstract][Full Text] [Related]
11. Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.
Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
BJOG; 2024 Jul; 131(8):1089-1101. PubMed ID: 38196326
[TBL] [Abstract][Full Text] [Related]
12. First-trimester serum biomarkers in twin pregnancies and adverse obstetric outcomes-a single center cohort study.
Queirós A; Gomes L; Pereira I; Charepe N; Plancha M; Rodrigues S; Cohen Á; Alves M; Papoila AL; Simões T
Arch Gynecol Obstet; 2024 Jul; 310(1):315-325. PubMed ID: 38734998
[TBL] [Abstract][Full Text] [Related]
13. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
15. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
[TBL] [Abstract][Full Text] [Related]
16. sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study.
Bonacina E; Armengol-Alsina M; Hurtado I; Garcia-Manau P; Ferrer-Oliveras R; Monreal S; Pancorbo M; Mendoza M; Carreras E
J Obstet Gynaecol; 2022 Oct; 42(7):2840-2845. PubMed ID: 35980876
[TBL] [Abstract][Full Text] [Related]
17. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
18. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic imbalance in pre-eclampsia and fetal growth restriction: enhanced soluble fms-like tyrosine kinase-1 binding or diminished production of placental growth factor?
Kluivers ACM; Biesbroek A; Visser W; Saleh L; Russcher H; Danser AHJ; Neuman RI
Ultrasound Obstet Gynecol; 2023 Apr; 61(4):466-473. PubMed ID: 36191149
[TBL] [Abstract][Full Text] [Related]
20. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
